Inari Medical, Inc. (NASDAQ:NARI) Q2 2023 Earnings Call Transcript August 2, 2023 4:30 PM ET

Company Participants

John Hsu - Vice President of Investor Relations

Drew Hykes - President and CEO

Mitch Hill - CFO

Tom Tu - Chief Medical Officer

Conference Call Participants

Travis Steed - Bank of America

Kallum Titchmarsh - Morgan Stanley

Larry Biegelsen - Wells Fargo

William Plovanic – Canaccord

Marie Thibault - BTIG

Adam Maeder - Piper Sandler

Mike Sarcone - Jeffries

Richard Newitter - Truist Securities

David Rescott - Baird

Chris Pasquale - Nephron Research

Operator

Good day ladies and gentlemen and welcome to Inari Medical Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. [Operator instructions].

And now I will turn the call over to John Hsu, Vice President of Investor Relations. Please go ahead.

John Hsu

Thank you, operator. Welcome to Inari's second quarter 2023 earnings call. Joining me on today's call are Drew Hykes, President and Chief Executive Officer; and Mitch Hill, Chief Financial Officer. This call will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

All statements made on this call that do not relate to matters of historical facts should be considered forward-looking statements, including statements regarding the markets in which Inari operates, trends and expectations for Inari's products and technology, trends in demand for Inari's products, Inari's expected financial performance, expenses and position in the market; and the impact of COVID-19 on Inari's operations and Inari's customers' operations.

These statements are neither promises nor guarantees and involve known and unknown risks and uncertainties that could cause actual results, performance or achievements to differ materially from any results, performance or achievements expressed or implied by the forward-looking statements. Please review Inari's most recent filings with the SEC, particularly the risk factors described in Inari's annual report on Form 10-K for the year ended December 31, 2022, for additional information. Any forward-looking statements provided during this call, including projections for future performance, are based on management's expectations as of today.

Inari undertakes no obligation to update these statements, except as required by applicable law. Inari's press release for the second quarter 2023 results is available on Inari's website, www.inarimedical.com, under the Investors section and includes additional details about Inari’s financial results. Inari’s website also has the latest SEC filings, which you are encouraged to review. A recording of today’s call will be available on Inari’s website by 5:00 p.m. Pacific Time today.